Bob Herpen

1 week ago | healio.com | Bob Herpen |Christopher G. Favilla

Key takeaways: Rapid, reliable detection in a pre-hospital setting is critical ahead of treating large vessel occlusion stroke. The Open-Motion device will undergo a future validation study to further determine its viability. Large vessel occlusion-type strokes are urgent enough that a single clinical scale utilized for detection in a pre-hospital setting may lead to misdiagnosis that endangers the patient, according to new research.

1 week ago | healio.com | Bob Herpen

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

1 week ago | healio.com | Bob Herpen

Key takeaways: The program offered interaction and education on a broad range of brain-health related topics in group settings. The overall program and its individual sections registered high participant satisfaction. A psychosocial educational intervention centered on principal dementia risk factors and offered to older adults concerned about brain health may be feasible for addressing these issues in a proactive manner, according to a speaker.

1 week ago | healio.com | Bob Herpen

Key takeaways: The framework centers on clinical, imaging, biomarker and external influences on TBI. The framework can be applied to patients with a full range of Glasgow Coma Scores. An updated framework for addressing traumatic brain injury places the focus on the acute phase, while considering internal, external and modifying factors that influence outcomes from these events, researchers wrote in The Lancet Neurology.

2 weeks ago | healio.com | Bob Herpen |Joshua A. Bornhorst

Key takeaways: Neurofilament light chain holds potential as an indicator of ALS, as in other neurodegenerative conditions. To utilize NfL effectively, a physician with expertise in neurological biomarkers will likely be required. In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for blood-based biomarkers to assist clinicians in early detection and treatment efforts. Healio spoke with Joshua A.